Published on
Updated
Reading 2 mins.
Vaccination against Covid-19 would have prevented 19.8 million deaths in the first year following the introduction of the vaccines in December 2020, according to an initial modeling study published on June 24.
An unprecedented and detailed study
The study, published in The Lancet Infectious Diseasesis based on data from 185 countries and territories, from December 8, 2020 to December 8, 2021. It is the first to attempt to estimate the deaths averted directly and indirectly as a result of vaccination against Covid-19.
For this, it uses the official figures of deaths with Covid but also the total excess deaths of each country (or estimates when official data was not available).
Excess mortality corresponds to the difference between the number of people who died (regardless of the cause of their death) and the number of expected deaths (based on past data). Where official data was not available, the team used estimates of all-cause excess mortality. These analyzes were compared to an alternative hypothetical scenario in which no vaccine would have been administered.
The model accounted for variation in vaccination rates across countries, as well as differences in vaccine effectiveness in each country based on the types of vaccines known to have been primarily used in those regions. China was not included in the analysis due to its large population and very strict containment measures, which would have skewed the results, it said.
Consult a GP online
“60,000 additional deaths” could have been avoided
According to this study, high- and middle-income countries accounted for the highest number of deaths averted (12.2 million out of 19.8 million), reflecting inequalities in access to vaccines around the world.
Nearly 600,000 additional deaths could have been prevented if the World Health Organization (WHO) target of vaccinating 40% of the population in every country by the end of 2021 had been reached, she concludes.
“Our results show that millions of lives have likely been saved by making vaccines available to people everywhere“Said Dr Oliver Watson, lead author of the study, from Imperial College London, quoted in the journal’s statement. “However, we could have done more“.